Citation Classic Genesis and Outcome of a Breast Cancer Trial to Develop the Aromatase Inhibitor Anastrozole

被引：1
|
作者：
Howell, Anthony [1 ]
机构：
[1] Univ Manchester, Christie NHS Fdn Trust, Manchester Breast Ctr, Manchester M20 4BX, Lancs, England
来源：
CLINICAL CHEMISTRY | 2012年 / 58卷 / 04期
关键词：
ARIMIDEX; TAMOXIFEN;
D O I：
10.1373/clinchem.2011.181206
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：782 / 783
页数：2
相关论文
共 50 条
  • [41] Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer
    Dixon, J. Michael
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 453 - 463
  • [42] Static disease (sd) of long duration (>=24 weeks) is an important remission criterion in breast cancer patients treated with the aromatase inhibitor anastrozole (AN)
    Robertson, JFR
    Lee, D
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 667 - 667
  • [43] Aromatase inhibitor cuts risk of recurrence of breast cancer
    White, C
    BRITISH MEDICAL JOURNAL, 2004, 328 (7440): : 599 - 599
  • [44] Whole genome sequencing and analysis in a clinical trial setting: Aromatase inhibitor therapy in breast cancer
    Mardis, Elaine
    CANCER RESEARCH, 2011, 71
  • [45] Aromatase inhibitor as neoadjuvant hormone therapy for breast cancer
    Utsumi, T.
    Kobayashi, N.
    Hanada, H.
    Mizoguchi, Y.
    Kuroda, M.
    EJC SUPPLEMENTS, 2008, 6 (07): : 128 - 128
  • [46] Recent advances in aromatase inhibitor therapy for breast cancer
    Assikis, VJ
    Buzdar, A
    SEMINARS IN ONCOLOGY, 2002, 29 (03) : 120 - 128
  • [47] Guideline adds aromatase inhibitor for breast cancer prevention
    不详
    FORMULARY, 2013, 48 (08) : 243 - +
  • [48] AR Overexpression and Aromatase Inhibitor Resistance in Breast Cancer
    Rechoum, Y.
    Iacopetta, D.
    Barone, I.
    Ando', S.
    Morales, S. F.
    Weigel, N. L.
    Fuqua, S. A. W.
    CANCER RESEARCH, 2011, 71
  • [49] Major breast cancer trial gives high marks to anastrozole
    Maurice, John
    LANCET ONCOLOGY, 2014, 15 (01): : E6 - E6
  • [50] Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer - The POETIC* Trial (CRUK/07/015)
    Robertson, John F. R.
    Dowsett, Mitchell
    Bliss, Judith M.
    Morden, James P.
    Wilcox, Maggie
    Evans, Abigail
    Holcombe, Chris
    Horgan, Kieran
    Kirwan, Cliona
    Mallon, Elizabeth
    Sibbering, Mark
    Skene, Anthony
    Vidya, Raghavan
    Cheang, Maggie
    Banerji, Jane
    Kilburn, Lucy
    Dodson, Andrew
    Smith, Ian
    CANCER RESEARCH, 2018, 78 (04)
12345